Pharmaceutical formulation containing bittering agent
US7141250B2 · kind B2 · utility
209Cited by
9References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 2002 |
| Grant date | Nov 28, 2006 |
| Priority date | — |
| Expiry date | Nov 11, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2054
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse; and an effective amount of a bittering agent to impart a bitter taste to an abuser upon administration of said dosage form after tampering.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.